OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice
Michaele B. Manigrasso, Piul S. Rabbani, Lander Egaña-Gorroño, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 621
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Pathophysiology of RAGE in inflammatory diseases
Hanbing Dong, Yue Zhang, Yu Huang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 113

AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer
Changfeng Li, Yuanda Liu, Chang Liu, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 783
Closed Access | Times Cited: 3

The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease
Yinghui Huang, Wang Xin, Jiachuan Xiong, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 45

Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors
Wenge Zheng, Huijuan Li, Yuyo Go, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4588-4588
Open Access | Times Cited: 45

RAGE Inhibitors in Neurodegenerative Diseases
V. Prakash Reddy, Puspa Aryal, Pallavi Soni
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1131-1131
Open Access | Times Cited: 31

Tetrahedral Framework Nucleic Acids Based Small Interfering RNA Targeting Receptor for Advanced Glycation End Products for Diabetic Complications Treatment
Zhengwen Cai, Yong Li, Long Bai, et al.
ACS Nano (2023) Vol. 17, Iss. 22, pp. 22668-22683
Closed Access | Times Cited: 28

Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy
Veronica Vella, Rosamaria Lappano, Eduardo Bonavita, et al.
Endocrine Reviews (2023) Vol. 44, Iss. 4, pp. 693-723
Open Access | Times Cited: 27

Cholesterol Metabolism in Cancer and Cell Death
Fangquan Chen, Yanjiao Lu, Junhao Lin, et al.
Antioxidants and Redox Signaling (2023) Vol. 39, Iss. 1-3, pp. 102-140
Closed Access | Times Cited: 20

Advances in secondary prevention mechanisms of macrovascular complications in type 2 diabetes mellitus patients: a comprehensive review
Huifang Guan, Jiaxing Tian, Ying Wang, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 7

Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases
Harbinder Singh, Devendra K. Agrawal
Molecules (2022) Vol. 27, Iss. 21, pp. 7311-7311
Open Access | Times Cited: 24

The AGE-RAGE Axis and the Pathophysiology of Multimorbidity in COPD
Niki L. Reynaert, Lowie E.G.W. Vanfleteren, Timothy N. Perkins
Journal of Clinical Medicine (2023) Vol. 12, Iss. 10, pp. 3366-3366
Open Access | Times Cited: 15

DIAPH1-MFN2 interaction regulates mitochondria-SR/ER contact and modulates ischemic/hypoxic stress
Gautham Yepuri, Lisa Ramirez, Gregory G. Theophall, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15

RAGE pathway activation and function in chronic kidney disease and COVID-19
Colleen S. Curran, Jeffrey B. Kopp
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 19

Obesity and Overweight: Probing Causes, Consequences, and Novel Therapeutic Approaches Through the American Heart Association's Strategically Focused Research Network
Jeanne M. Clark, W. Timothy Garvey, Kevin D. Niswender, et al.
Journal of the American Heart Association (2023) Vol. 12, Iss. 4
Open Access | Times Cited: 11

DIAPH1 mediates progression of atherosclerosis and regulates hepatic lipid metabolism in mice
Laura M Senatus, Lander Egaña-Gorroño, Raquel López‐Díez, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 11

Extracellular vesicle encapsulated Homer1a as novel nanotherapeutics against intracerebral hemorrhage in a mouse model
Xiaowei Fei, Li Wang, Yanan Dou, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 4

Eugenol-loaded polyurethane gelatin dressing for efficient angiogenesis and antibacterial effects in refractory diabetic wound defect healing
Zhengzhe Han, Ang Li, Zichao Xue, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132619-132619
Open Access | Times Cited: 4

The Advanced Glycation End-Products (AGE)–Receptor for AGE System (RAGE): An Inflammatory Pathway Linking Obesity and Cardiovascular Diseases
Elena Vianello, Antonio Paolo Beltrami, Aneta Aleksova, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 8, pp. 3707-3707
Open Access

Expression and Purification of Transmembrane Domain of RAGE for Structural-Dynamic NMR Studies
Sofya M. Dolotova, D. D. Plashchinskaia, Yaroslav V. Bershatsky, et al.
Biochemistry (Moscow) Supplement Series A Membrane and Cell Biology (2025) Vol. 19, Iss. 1, pp. 35-40
Closed Access

The RAGE/DIAPH1 Signaling Axis & Implications for the Pathogenesis of Diabetic Complications
Ravichandran Ramasamy, Alexander Shekhtman, Ann Marie Schmidt
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4579-4579
Open Access | Times Cited: 16

Novel insights into RAGE signaling pathways during the progression of amyotrophic lateral sclerosis in RAGE-deficient SOD1 G93A mice
Natalia Nowicka, Kamila Zglejc‐Waszak, Judyta K. Juranek, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299567-e0299567
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top